You are using an outdated browser. Please upgrade your browser to improve your experience.

mucolipidosis type III

Disease Summary
Associated Targets (1)
Tbio

1


GARD Rare
Mondo Description Mucolipidosis III alpha/beta (MLIII alpha/beta) is a lysosomal disorder characterized by progressive slowing of the growth rate from early childhood, stiffness and pain in joints, gradual coarsening of facial features, moderate developmental delay and mild intellectual disability in most patients.
Uniprot Description Autosomal recessive disease of lysosomal enzyme targeting. Clinically MLIII is characterized by restricted joint mobility, skeletal dysplasia, and short stature. Mildly coarsened facial features and thickening of the skin have been described. Cardiac valvular disease and corneal clouding may also occur. Half of the reported patients show learning disabilities or mental retardation.
Mondo Term and Equivalent IDs
MONDO:0018931:  mucolipidosis type III
GARD:0003806: 
Orphanet:577: 
SCTID:65764006: 
UMLS:CN237499: